CAS: 92689-49-1 - Annamycin
Formula:C26H25IO11
InChI:InChI=1S/C26H25IO11/c1-9-19(30)24(35)18(27)25(37-9)38-13-7-26(36,14(29)8-28)6-12-15(13)23(34)17-16(22(12)33)20(31)10-4-2-3-5-11(10)21(17)32/h2-5,9,13,18-19,24-25,28,30,33-36H,6-8H2,1H3/t9-,13-,18+,19-,24-,25-,26-/m0/s1
InChI key:InChIKey=CIDNKDMVSINJCG-GKXONYSUSA-N
SMILES:O=C1C=2C=CC=CC2C(=O)C=3C(O)=C4C(=C(O)C13)CC(O)(C(=O)CO)CC4OC5OC(C)C(O)C(O)C5I
- Synonyms:
- (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,6-dideoxy-2-iodo-alpha-L-mannopyranoside
- (7S,9S)-7-[(2,6-Dideoxy-2-iodo-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-5,12-naphthacenedione
- (7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-Dihydroxy-3-iodo-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione
- 5,12-Naphthacenedione, 7-[(2,6-dideoxy-2-iodo-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-, (7S,9S)-
- 5,12-Naphthacenedione, 7-[(2,6-dideoxy-2-iodo-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-, (7S,9S)-
- Annamycin
- 5,12-Naphthacenedione, 7-[(2,6-dideoxy-2-iodo-α-L-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-, (7S,9S)-
- Naxtarubicin
- (7S,9S)-7-[(2,6-Dideoxy-2-iodo-α-L-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-5,12-naphthacenedione
- 5,12-Naphthacenedione, 7-[(2,6-dideoxy-2-iodo-α-L-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-, (7S,9S)-
- See more synonyms
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Annamycin REF: 4Z-A-324001CAS: 92689-49-1 | - - - | To inquire | Mon 13 Jan 25 |
| Annamycin-d3 REF: 4Z-A-324002CAS: 92689-49-1 | - - - | To inquire | Mon 13 Jan 25 |
 | Annamycin REF: TR-A291365CAS: 92689-49-1 | - - - | 9,038.00 € | Tue 18 Feb 25 |
 | Annamycin REF: TM-T68326CAS: 92689-49-1 | - - - | To inquire | Mon 10 Mar 25 |
 | Annamycin REF: 3D-FA150912CAS: 92689-49-1 | Min. 95% | - - - | Discontinued product |
Ref: 4Z-A-324001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-A-324002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Annamycin
Controlled ProductCAS:92689-49-1
Formula:
C26H25IO11
Color and Shape:
Off-White
Molecular weight:
640.375
Ref: TR-A291365
| 50mg | 9,038.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Annamycin
CAS:92689-49-1
Annamycin, a semi-synthetic doxorubicin derivative, binds DNA, blocks topoisomerase II, and evades MDR, inhibiting DNA/RNA/protein …
Formula:
C26H25IO11
Color and Shape:
Liquid
Molecular weight:
640.37
Ref: TM-T68326
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
Annamycin
CAS:92689-49-1
Annamycin is a pyrimidine compound that exhibits cytotoxic activity against cancer cells, including CD-1 mice …
Formula:
C26H25IO11
Purity:
Min. 95%
Molecular weight:
640.37 g/mol
Ref: 3D-FA150912
| Undefined size | Discontinued | Request information |
